Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
Top Cited Papers
Open Access
- 3 May 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 92 (6) , 856-860
- https://doi.org/10.1002/ijc.1282
Abstract
NY‐ESO‐1, a member of the CT (cancer/testis) family of antigens, is expressed in normal testis and in a range of human tumor types. Knowledge of NY‐ESO‐1 expression has depended on RT‐PCR detection of mRNA and there is a need for detecting NY‐ESO‐1 at the protein level. In the present study, a method for the immunochemical detection of NY‐ESO‐1 in paraffin‐embedded tissues has been developed and used to define the expression pattern of NY‐ESO‐1 in normal tissues and in a panel of human tumors. No normal tissue other than testis showed NY‐ESO‐1 reactivity, and expression in testis was restricted to germ cells particularly spermatogonia. In human tumors, the frequency of NY‐ESO‐1 antigen expression corresponds with past analysis of NY‐ESO‐1 mRNA expression e.g., 20–30% of lung cancers, bladder cancers and melanoma, and no expression in colon and renal cancer. Co‐typing of NY‐ESO‐1 antigen and mRNA expression in a large panel of lung cancers showed a good correlation. There is great variability in NY‐ESO‐1 expression in individual tumors, ranging from an infrequent homogeneous pattern of staining to highly heterogeneous antigen expression.Keywords
This publication has 27 references indexed in Scilit:
- CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysisInternational Journal of Cancer, 2000
- Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical eventsInternational Journal of Cancer, 1999
- Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1 to human chromosome Xq28Cytogenetic and Genome Research, 1997
- Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cellsInternational Journal of Cancer, 1996
- Human neoplasms elicit multiple specific immune responses in the autologous host.Proceedings of the National Academy of Sciences, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytesImmunity, 1995
- MAGE‐1 gene product is a cytoplasmic proteinInternational Journal of Cancer, 1994
- Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.Proceedings of the National Academy of Sciences, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991